PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE - Q4 2021 holdings

$62.5 Million is the total value of PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's 10 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 76.5% .

 Value Shares↓ Weighting
SPY SellSPDR S&P 500 ETF TRtr unit$21,373,000
-9.5%
45,000
-18.2%
34.19%
+28.1%
NVGS SellNAVIGATOR HLDGS LTD$8,938,000
-20.3%
1,007,716
-20.0%
14.30%
+12.8%
AEM NewAGNICO EAGLE MINES LTD$8,768,000165,000
+100.0%
14.02%
EPSN SellEPSILON ENERGY LTD$7,825,000
-12.2%
1,377,609
-0.5%
12.52%
+24.2%
APA NewAPA CORPORATION$5,378,000200,000
+100.0%
8.60%
AR SellANTERO RESOURCES CORP$5,250,000
-14.1%
300,000
-7.7%
8.40%
+21.5%
IRIX SellIRIDEX CORP$3,039,000
-49.4%
497,337
-36.5%
4.86%
-28.4%
BFS  SAUL CTRS INC$1,326,000
+20.3%
25,0000.0%2.12%
+70.2%
ATNI BuyATN INTL INC$400,000
+1.5%
10,000
+19.0%
0.64%
+43.8%
ATGE NewADTALEM GLOBAL ED INC$222,0007,500
+100.0%
0.36%
AGI ExitALAMOS GOLD INC NEW$0-20,000
-100.0%
-0.16%
MLHR ExitMILLER HERMAN INC$0-10,000
-100.0%
-0.43%
EEFT ExitEURONET WORLDWIDE INC$0-10,000
-100.0%
-1.44%
UBER ExitUBER TECHNOLOGIES INC$0-30,000
-100.0%
-1.52%
CS ExitCREDIT SUISSE GROUPsponsored adr$0-200,000
-100.0%
-2.23%
CHK ExitCHESAPEAKE ENERGY CORP$0-75,000
-100.0%
-5.22%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-46,646
-100.0%
-5.31%
CF ExitCF INDS HLDGS INC$0-90,000
-100.0%
-5.68%
NEM ExitNEWMONT CORP$0-100,000
-100.0%
-6.14%
VRS ExitVERSO CORPcl a$0-300,000
-100.0%
-7.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NAVIGATOR HOLDINGS LTD40Q3 202338.2%
IRIDEX CORP40Q3 202323.4%
COMMUNITY BANKERS TR CORP28Q3 202010.5%
PAR PETROLEUM CORP26Q2 202015.3%
REATA PHARMACEUTICALS INC22Q3 202134.4%
EPSILON ENERGY LTD19Q3 202316.6%
CAREDX INC16Q2 20196.6%
FORESTAR GROUP INC16Q4 20193.0%
SPDR S&P 500 ETF TR13Q3 202234.2%
HOWARD HUGHES CORP13Q1 20195.5%

View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete holdings history.

Latest significant ownerships (13-D/G)
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Epsilon Energy Ltd.June 12, 2023900,0003.9%
IRIDEX CORPNovember 23, 2022963,2506.0%
CareDx, Inc.January 24, 20181,133,0003.9%
CASCADE MICROTECH INCNovember 04, 2014950,0005.8%
SPECTRANETICS CORPOctober 02, 20121,700,0004.9%
DUSA PHARMACEUTICALS INCMay 26, 20111,218,5005.0%
SENORX INCMay 07, 2010140,9930.8%
TRANSCOMMUNITY FINANCIAL CORPMarch 21, 2008445,0009.7%
ARONEX PHARMACEUTICALS INCJanuary 25, 20001,138,1115.0%
APPLIED IMAGING CORPJanuary 20, 2000483,8334.0%

View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
SC 13D/A2023-06-12
13F-HR2023-05-15
13F-HR2023-02-13
SC 13D2022-11-23
13F-HR2022-11-14
13F-HR2022-08-16
13F-HR2022-05-16

View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete filings history.

Compare quarters

Export PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's holdings